These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 32739119)

  • 21. Relative effectiveness of the adjuvanted vs non-adjuvanted seasonal influenza vaccines against severe laboratory-confirmed influenza among hospitalized Italian older adults.
    Domnich A; Panatto D; Pariani E; Napoli C; Chironna M; Manini I; Rizzo C; Orsi A; Icardi G;
    Int J Infect Dis; 2022 Dec; 125():164-169. PubMed ID: 36332902
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relative Effectiveness of Cell-Based Versus Egg-Based Quadrivalent Influenza Vaccines in Adults During the 2019-2020 Influenza Season in the United States.
    Imran M; Ortiz JR; McLean HQ; Fisher L; O'Brien D; Bonafede M; Mansi JA; Boikos C
    Open Forum Infect Dis; 2022 Oct; 9(10):ofac532. PubMed ID: 36320195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relative Effectiveness of Adjuvanted Trivalent Inactivated Influenza Vaccine Versus Egg-derived Quadrivalent Inactivated Influenza Vaccines and High-dose Trivalent Influenza Vaccine in Preventing Influenza-related Medical Encounters in US Adults ≥ 65 Years During the 2017-2018 and 2018-2019 Influenza Seasons.
    Boikos C; Fischer L; O'Brien D; Vasey J; Sylvester GC; Mansi JA
    Clin Infect Dis; 2021 Sep; 73(5):816-823. PubMed ID: 33605977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relative Effectiveness of Cell-Cultured and Egg-Based Influenza Vaccines Among Elderly Persons in the United States, 2017-2018.
    Izurieta HS; Chillarige Y; Kelman J; Wei Y; Lu Y; Xu W; Lu M; Pratt D; Chu S; Wernecke M; MaCurdy T; Forshee R
    J Infect Dis; 2019 Sep; 220(8):1255-1264. PubMed ID: 30561688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relative Effectiveness of the Cell-Cultured Quadrivalent Influenza Vaccine Compared to Standard, Egg-derived Quadrivalent Influenza Vaccines in Preventing Influenza-like Illness in 2017-2018.
    Boikos C; Sylvester GC; Sampalis JS; Mansi JA
    Clin Infect Dis; 2020 Dec; 71(10):e665-e671. PubMed ID: 32253431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An Economic Comparison of Influenza Vaccines Recommended for Use in Eligible Adults under 65 Years in the United Kingdom.
    Maschio M; Kohli MA; Ashraf M; Drummond MF; Weinstein MC; Mould-Quevedo JF
    Vaccines (Basel); 2022 Apr; 10(4):. PubMed ID: 35455348
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-risk Cardiovascular Disease: A Randomized Clinical Trial.
    Vardeny O; Kim K; Udell JA; Joseph J; Desai AS; Farkouh ME; Hegde SM; Hernandez AF; McGeer A; Talbot HK; Anand I; Bhatt DL; Cannon CP; DeMets D; Gaziano JM; Goodman SG; Nichol K; Tattersall MC; Temte JL; Wittes J; Yancy C; Claggett B; Chen Y; Mao L; Havighurst TC; Cooper LS; Solomon SD;
    JAMA; 2021 Jan; 325(1):39-49. PubMed ID: 33275134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of the quadrivalent high-dose influenza vaccine for prevention of cardiovascular and respiratory events in people aged 65 years and above: Rationale and design of a real-world pragmatic randomized clinical trial.
    Hollingsworth R; Palmu A; Pepin S; Dupuy M; Shrestha A; Jokinen J; Syrjänen R; Nealon J; Samson S; De Bruijn I
    Am Heart J; 2021 Jul; 237():54-61. PubMed ID: 33722585
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of influenza vaccine in the elderly.
    Nichol KL; Margolis KL; Wouremna J; von Sternberg T
    Gerontology; 1996; 42(5):274-9. PubMed ID: 8940650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Cost-Effectiveness of Vaccination of Older Adults with an MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared to Other Available Quadrivalent Vaccines in Germany.
    Kohli MA; Maschio M; Cartier S; Mould-Quevedo J; Fricke FU
    Vaccines (Basel); 2022 Aug; 10(9):. PubMed ID: 36146464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaccine effectiveness of recombinant and standard dose influenza vaccines against outpatient illness during 2018-2019 and 2019-2020 calculated using a retrospective test-negative design.
    Zimmerman RK; Dauer K; Clarke L; Nowalk MP; Raviotta JM; Balasubramani GK
    Hum Vaccin Immunother; 2023 Dec; 19(1):2177461. PubMed ID: 36809982
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of the Cell-Derived Inactivated Quadrivalent Influenza Vaccine in Individuals at High Risk of Influenza Complications in the 2018-2019 United States Influenza Season.
    Boikos C; Imran M; Nguyen VH; Ducruet T; Sylvester GC; Mansi JA
    Open Forum Infect Dis; 2021 Jul; 8(7):ofab167. PubMed ID: 34327253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccine effectiveness of cell-culture relative to egg-based inactivated influenza vaccine during the 2017-18 influenza season.
    Klein NP; Fireman B; Goddard K; Zerbo O; Asher J; Zhou J; King J; Lewis N
    PLoS One; 2020; 15(2):e0229279. PubMed ID: 32101582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative effectiveness of high dose versus adjuvanted influenza vaccine: A retrospective cohort study.
    van Aalst R; Gravenstein S; Mor V; Mahmud SM; Wilschut J; Postma M; Chit A
    Vaccine; 2020 Jan; 38(2):372-379. PubMed ID: 31606249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunogenicity and safety of a cell culture-based quadrivalent influenza vaccine in adults: A Phase III, double-blind, multicenter, randomized, non-inferiority study.
    Bart S; Cannon K; Herrington D; Mills R; Forleo-Neto E; Lindert K; Abdul Mateen A
    Hum Vaccin Immunother; 2016 Sep; 12(9):2278-88. PubMed ID: 27322354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparing the impact of high-dose versus standard dose influenza vaccines on hospitalization cost for cardiovascular and respiratory diseases: Economic assessment in the US Veteran population during 5 respiratory seasons using an instrumental variable method.
    van Aalst R; Russo EM; Neupane N; Mahmud SM; Wilschut J; Samson SI; Chit A; Postma M; Young-Xu Y
    Vaccine; 2021 Mar; 39 Suppl 1():A51-A55. PubMed ID: 32576459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative effectiveness of high-dose versus standard-dose influenza vaccination in community-dwelling veterans.
    Richardson DM; Medvedeva EL; Roberts CB; Linkin DR;
    Clin Infect Dis; 2015 Jul; 61(2):171-6. PubMed ID: 25829001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety of quadrivalent live attenuated influenza vaccine in subjects aged 2-49years.
    Baxter R; Eaton A; Hansen J; Aukes L; Caspard H; Ambrose CS
    Vaccine; 2017 Mar; 35(9):1254-1258. PubMed ID: 28162825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Review of Analyses Estimating Relative Vaccine Effectiveness of Cell-Based Quadrivalent Influenza Vaccine in Three Consecutive US Influenza Seasons.
    Boikos C; McGovern I; Molrine D; Ortiz JR; Puig-Barberà J; Haag M
    Vaccines (Basel); 2022 Jun; 10(6):. PubMed ID: 35746504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relative vaccine efficacy of high-dose versus standard-dose influenza vaccines in preventing probable influenza in a Medicare Fee-for-Service population.
    Paudel M; Mahmud S; Buikema A; Korrer S; Van Voorhis D; Brekke L; Chit A
    Vaccine; 2020 Jun; 38(29):4548-4556. PubMed ID: 32446835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.